- Home
- UTHR vs DT Comparison
UTHR vs DT Comparison
Compare UTHR & DT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- DT
- Stock Information
- Founded
- UTHR 1996
- DT 2005
- Country
- UTHR United States
- DT United States
- Employees
- UTHR N/A
- DT N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- DT Computer Software: Prepackaged Software
- Sector
- UTHR Health Care
- DT Technology
- Exchange
- UTHR Nasdaq
- DT Nasdaq
- Market Cap
- UTHR 16.1B
- DT 18.7B
- IPO Year
- UTHR 1999
- DT 2019
- Fundamental
- Price
- UTHR $361.10
- DT $59.88
- Analyst Decision
- UTHR Buy
- DT Buy
- Analyst Count
- UTHR 13
- DT 26
- Target Price
- UTHR $382.08
- DT $61.04
- AVG Volume (30 Days)
- UTHR 385.3K
- DT 3.7M
- Earning Date
- UTHR 02-26-2025
- DT 01-30-2025
- Dividend Yield
- UTHR N/A
- DT N/A
- EPS Growth
- UTHR 25.10
- DT 143.80
- EPS
- UTHR 22.72
- DT 1.60
- Revenue
- UTHR $2,756,200,000.00
- DT $1,634,366,000.00
- Revenue This Year
- UTHR $26.10
- DT $21.49
- Revenue Next Year
- UTHR $10.43
- DT $15.19
- P/E Ratio
- UTHR $15.89
- DT $37.41
- Revenue Growth
- UTHR 25.04
- DT 19.81
- 52 Week Low
- UTHR $218.41
- DT $39.42
- 52 Week High
- UTHR $417.82
- DT $63.00
- Technical
- Relative Strength Index (RSI)
- UTHR 48.08
- DT 55.44
- Support Level
- UTHR $364.62
- DT $60.92
- Resistance Level
- UTHR $383.51
- DT $62.66
- Average True Range (ATR)
- UTHR 11.17
- DT 1.63
- MACD
- UTHR 1.30
- DT -0.11
- Stochastic Oscillator
- UTHR 42.76
- DT 55.69
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.